Cargando…

Novel associations of bile acid diarrhoea with fatty liver disease and gallstones: a cohort retrospective analysis

BACKGROUND: Bile acid diarrhoea (BAD) is a common cause of chronic diarrhoea with a population prevalence of primary BAD around 1%. Previous studies have identified associations with low levels of the ileal hormone fibroblast growth factor 19 (FGF19), obesity and hypertriglyceridaemia. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Appleby, Richard N, Nolan, Jonathan D, Johnston, Ian M, Pattni, Sanjeev S, Fox, Jessica, Walters, Julian RF
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Functional and Motility Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663265/ https://www.ncbi.nlm.nih.gov/pubmed/29119003 http://dx.doi.org/10.1136/bmjgast-2017-000178

Ejemplares similares

‘What puts the ‘Hic’ into Hiccups?’
por: Seifi, Ali, et al.
Publicado: (2022)

Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea
por: Pattni, Sanjeev S, et al.
Publicado: (2012)

Gastric microbiota in the functional dyspepsia patients treated with probiotic yogurt
por: Nakae, Hirohiko, et al.
Publicado: (2016)

Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia
por: Igarashi, Muneki, et al.
Publicado: (2017)

Practical multidisciplinary framework for the assessment and management of patients with unexplained chronic aerodigestive symptoms
por: Quigley, Nathan, et al.
Publicado: (2023)

Persistent constipation and abdominal adverse events with newer treatments for constipation
por: Sonu, Irene, et al.
Publicado: (2016)

Incidence of ‘new-onset’ constipation and associated factors during lockdown due to the COVID-19 pandemic
por: Remes-Troche, Jose Maria, et al.
Publicado: (2021)

A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor, for Chronic Idiopathic Constipation
por: Chey, William D, et al.
Publicado: (2011)

Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?
por: Berstad, Arnold, et al.
Publicado: (2012)

Diagnostic pitfalls in functional neurological disorders
por: Pimentel, Lucio Huebra, et al.
Publicado: (2022)

Role of myosin Va in purinergic vesicular neurotransmission in the gut
por: Chaudhury, Arun, et al.
Publicado: (2012)

An organotypic slice model for ex vivo study of neural, immune, and microbial interactions of mouse intestine
por: Schwerdtfeger, Luke A., et al.
Publicado: (2015)

Hydroxy-α sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9
por: Kubota, Kunitsugu, et al.
Publicado: (2015)

The role of K(+) conductances in regulating membrane excitability in human gastric corpus smooth muscle
por: Lee, Ji Yeon, et al.
Publicado: (2015)

Electrophysiological characterization of human rectal afferents
por: Ng, Kheng-Seong, et al.
Publicado: (2016)

Utility of wireless motility capsule and lactulose breath testing in the evaluation of patients with chronic functional bloating
por: Triadafilopoulos, George
Publicado: (2016)

Patients with symptoms of delayed gastric emptying have a high prevalence of oesophageal dysmotility, irrespective of scintigraphic evidence of gastroparesis
por: Triadafilopoulos, George, et al.
Publicado: (2017)

Clinical and manometric characteristics of patients with oesophagogastric outflow obstruction: towards a new classification
por: Triadafilopoulos, George, et al.
Publicado: (2018)

Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms
por: Su, Andrew, et al.
Publicado: (2017)

Evaluating the impact of an enhanced triage process on the performance and diagnostic yield of oesophageal physiology studies post COVID-19
por: Doyle, Rebecca, et al.
Publicado: (2021)

Rapid priority setting exercise on faecal incontinence for Cochrane Incontinence
por: Thomson, Katie H, et al.
Publicado: (2022)

miR‐10b‐5p rescues leaky gut linked with gastrointestinal dysmotility and diabetes
por: Zogg, Hannah, et al.
Publicado: (2023)

A pilot genome‐wide association study meta‐analysis of gastroparesis
por: Tavares, Leticia Camargo, et al.
Publicado: (2023)

A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
por: Rao, Satish, et al.
Publicado: (2012)

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Schoenfeld, Philip, et al.
Publicado: (2018)

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis
por: Emmanuel, Anton, et al.
Publicado: (2014)

Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome
por: Marquis, P, et al.
Publicado: (2014)

The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study
por: Riddle, Mark S, et al.
Publicado: (2016)

Association Between the Location of Diverticular Disease and the Irritable Bowel Syndrome: A Multicenter Study in Japan
por: Yamada, Eiji, et al.
Publicado: (2014)

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
por: Yiannakou, Yan, et al.
Publicado: (2015)

A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
por: Jamal, M Mazen, et al.
Publicado: (2015)

The Spectrum of Constipation-Predominant Irritable Bowel Syndrome and Chronic Idiopathic Constipation: US Survey Assessing Symptoms, Care Seeking, and Disease Burden
por: Heidelbaugh, Joel J, et al.
Publicado: (2015)

The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment?
por: Y Lee, Chooi
Publicado: (2013)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Distinct Abnormalities of Small Bowel and Regional Colonic Volumes in Subtypes of Irritable Bowel Syndrome Revealed by MRI
por: Lam, Ching, et al.
Publicado: (2017)

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
por: Miner Jr, Philip B, et al.
Publicado: (2017)

Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus
por: Rezaie, Ali, et al.
Publicado: (2017)

Tenapanor Treatment of Patients With Constipation-Predominant Irritable Bowel Syndrome: A Phase 2, Randomized, Placebo-Controlled Efficacy and Safety Trial
por: Chey, William D, et al.
Publicado: (2017)

Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome
por: Sayuk, Gregory S, et al.
Publicado: (2017)

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
por: Lacy, Brian E, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i1bqv4eqm7e9aivfkn880r9kth